The global Acyclovir Analogues market size is predicted to grow from US$ 1921 million in 2025 to US$ 2788 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
A class of antiviral drugs that are structurally related to acyclovir and share a similar mechanism of action by inhibiting viral DNA polymerase. These drugs are commonly used to treat herpesvirus infections, including herpes simplex virus (HSV), varicella-zoster virus (VZV), and cytomegalovirus (CMV). Examples include acyclovir, valacyclovir, penciclovir, and famciclovir.
United States market for Acyclovir Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Acyclovir Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Acyclovir Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Acyclovir Analogues players cover Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎cyclovir Analogues Industry Forecast鈥� looks at past sales and reviews total world Acyclovir Analogues sales in 2024, providing a comprehensive analysis by region and market sector of projected Acyclovir Analogues sales for 2025 through 2031. With Acyclovir Analogues sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acyclovir Analogues industry.
This Insight Report provides a comprehensive analysis of the global Acyclovir Analogues landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Acyclovir Analogues portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Acyclovir Analogues market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acyclovir Analogues and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acyclovir Analogues.
This report presents a comprehensive overview, market shares, and growth opportunities of Acyclovir Analogues market by product type, application, key players and key regions and countries.
Segmentation by Type:
Acyclovir
Valacyclovir
Penciclovir
Famciclovir
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Greater Pharma
LBS Labs
GlaxoSmithKline
Lex Ano
Salutas
Novartis
Teva
Stada Nordic
Cimed Industria de Medicamentos
Reman Drug
L.E.T.I.
Nichi-Iko Pharmaceutical
Choseido Pharmaceutical
Shiono Kemikaru
Towa Yakuhin
Wockhardt
Takata Pharmaceutical
Aliud
Amneal Pharma
Apotex
Arrow
Laboratoires Servier
Sanofi
Mylan
Orion Pharma
Pfizer
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acyclovir Analogues Market Size (2020-2031)
2.1.2 Acyclovir Analogues Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Acyclovir Analogues by Country/Region (2020, 2024 & 2031)
2.2 Acyclovir Analogues Segment by Type
2.2.1 Acyclovir
2.2.2 Valacyclovir
2.2.3 Penciclovir
2.2.4 Famciclovir
2.2.5 Other
2.3 Acyclovir Analogues Market Size by Type
2.3.1 Acyclovir Analogues Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Acyclovir Analogues Market Size Market Share by Type (2020-2025)
2.4 Acyclovir Analogues Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Acyclovir Analogues Market Size by Application
2.5.1 Acyclovir Analogues Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Acyclovir Analogues Market Size Market Share by Application (2020-2025)
3 Acyclovir Analogues Market Size by Player
3.1 Acyclovir Analogues Market Size Market Share by Player
3.1.1 Global Acyclovir Analogues Revenue by Player (2020-2025)
3.1.2 Global Acyclovir Analogues Revenue Market Share by Player (2020-2025)
3.2 Global Acyclovir Analogues Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Acyclovir Analogues by Region
4.1 Acyclovir Analogues Market Size by Region (2020-2025)
4.2 Global Acyclovir Analogues Annual Revenue by Country/Region (2020-2025)
4.3 Americas Acyclovir Analogues Market Size Growth (2020-2025)
4.4 APAC Acyclovir Analogues Market Size Growth (2020-2025)
4.5 Europe Acyclovir Analogues Market Size Growth (2020-2025)
4.6 Middle East & Africa Acyclovir Analogues Market Size Growth (2020-2025)
5 Americas
5.1 Americas Acyclovir Analogues Market Size by Country (2020-2025)
5.2 Americas Acyclovir Analogues Market Size by Type (2020-2025)
5.3 Americas Acyclovir Analogues Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acyclovir Analogues Market Size by Region (2020-2025)
6.2 APAC Acyclovir Analogues Market Size by Type (2020-2025)
6.3 APAC Acyclovir Analogues Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Acyclovir Analogues Market Size by Country (2020-2025)
7.2 Europe Acyclovir Analogues Market Size by Type (2020-2025)
7.3 Europe Acyclovir Analogues Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acyclovir Analogues by Region (2020-2025)
8.2 Middle East & Africa Acyclovir Analogues Market Size by Type (2020-2025)
8.3 Middle East & Africa Acyclovir Analogues Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Acyclovir Analogues Market Forecast
10.1 Global Acyclovir Analogues Forecast by Region (2026-2031)
10.1.1 Global Acyclovir Analogues Forecast by Region (2026-2031)
10.1.2 Americas Acyclovir Analogues Forecast
10.1.3 APAC Acyclovir Analogues Forecast
10.1.4 Europe Acyclovir Analogues Forecast
10.1.5 Middle East & Africa Acyclovir Analogues Forecast
10.2 Americas Acyclovir Analogues Forecast by Country (2026-2031)
10.2.1 United States Market Acyclovir Analogues Forecast
10.2.2 Canada Market Acyclovir Analogues Forecast
10.2.3 Mexico Market Acyclovir Analogues Forecast
10.2.4 Brazil Market Acyclovir Analogues Forecast
10.3 APAC Acyclovir Analogues Forecast by Region (2026-2031)
10.3.1 China Acyclovir Analogues Market Forecast
10.3.2 Japan Market Acyclovir Analogues Forecast
10.3.3 Korea Market Acyclovir Analogues Forecast
10.3.4 Southeast Asia Market Acyclovir Analogues Forecast
10.3.5 India Market Acyclovir Analogues Forecast
10.3.6 Australia Market Acyclovir Analogues Forecast
10.4 Europe Acyclovir Analogues Forecast by Country (2026-2031)
10.4.1 Germany Market Acyclovir Analogues Forecast
10.4.2 France Market Acyclovir Analogues Forecast
10.4.3 UK Market Acyclovir Analogues Forecast
10.4.4 Italy Market Acyclovir Analogues Forecast
10.4.5 Russia Market Acyclovir Analogues Forecast
10.5 Middle East & Africa Acyclovir Analogues Forecast by Region (2026-2031)
10.5.1 Egypt Market Acyclovir Analogues Forecast
10.5.2 South Africa Market Acyclovir Analogues Forecast
10.5.3 Israel Market Acyclovir Analogues Forecast
10.5.4 Turkey Market Acyclovir Analogues Forecast
10.6 Global Acyclovir Analogues Forecast by Type (2026-2031)
10.7 Global Acyclovir Analogues Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Acyclovir Analogues Forecast
11 Key Players Analysis
11.1 Greater Pharma
11.1.1 Greater Pharma Company Information
11.1.2 Greater Pharma Acyclovir Analogues Product Offered
11.1.3 Greater Pharma Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Greater Pharma Main Business Overview
11.1.5 Greater Pharma Latest Developments
11.2 LBS Labs
11.2.1 LBS Labs Company Information
11.2.2 LBS Labs Acyclovir Analogues Product Offered
11.2.3 LBS Labs Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 LBS Labs Main Business Overview
11.2.5 LBS Labs Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Acyclovir Analogues Product Offered
11.3.3 GlaxoSmithKline Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Lex Ano
11.4.1 Lex Ano Company Information
11.4.2 Lex Ano Acyclovir Analogues Product Offered
11.4.3 Lex Ano Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Lex Ano Main Business Overview
11.4.5 Lex Ano Latest Developments
11.5 Salutas
11.5.1 Salutas Company Information
11.5.2 Salutas Acyclovir Analogues Product Offered
11.5.3 Salutas Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Salutas Main Business Overview
11.5.5 Salutas Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Acyclovir Analogues Product Offered
11.6.3 Novartis Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Teva
11.7.1 Teva Company Information
11.7.2 Teva Acyclovir Analogues Product Offered
11.7.3 Teva Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Teva Main Business Overview
11.7.5 Teva Latest Developments
11.8 Stada Nordic
11.8.1 Stada Nordic Company Information
11.8.2 Stada Nordic Acyclovir Analogues Product Offered
11.8.3 Stada Nordic Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Stada Nordic Main Business Overview
11.8.5 Stada Nordic Latest Developments
11.9 Cimed Industria de Medicamentos
11.9.1 Cimed Industria de Medicamentos Company Information
11.9.2 Cimed Industria de Medicamentos Acyclovir Analogues Product Offered
11.9.3 Cimed Industria de Medicamentos Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cimed Industria de Medicamentos Main Business Overview
11.9.5 Cimed Industria de Medicamentos Latest Developments
11.10 Reman Drug
11.10.1 Reman Drug Company Information
11.10.2 Reman Drug Acyclovir Analogues Product Offered
11.10.3 Reman Drug Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Reman Drug Main Business Overview
11.10.5 Reman Drug Latest Developments
11.11 L.E.T.I.
11.11.1 L.E.T.I. Company Information
11.11.2 L.E.T.I. Acyclovir Analogues Product Offered
11.11.3 L.E.T.I. Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 L.E.T.I. Main Business Overview
11.11.5 L.E.T.I. Latest Developments
11.12 Nichi-Iko Pharmaceutical
11.12.1 Nichi-Iko Pharmaceutical Company Information
11.12.2 Nichi-Iko Pharmaceutical Acyclovir Analogues Product Offered
11.12.3 Nichi-Iko Pharmaceutical Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Nichi-Iko Pharmaceutical Main Business Overview
11.12.5 Nichi-Iko Pharmaceutical Latest Developments
11.13 Choseido Pharmaceutical
11.13.1 Choseido Pharmaceutical Company Information
11.13.2 Choseido Pharmaceutical Acyclovir Analogues Product Offered
11.13.3 Choseido Pharmaceutical Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Choseido Pharmaceutical Main Business Overview
11.13.5 Choseido Pharmaceutical Latest Developments
11.14 Shiono Kemikaru
11.14.1 Shiono Kemikaru Company Information
11.14.2 Shiono Kemikaru Acyclovir Analogues Product Offered
11.14.3 Shiono Kemikaru Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Shiono Kemikaru Main Business Overview
11.14.5 Shiono Kemikaru Latest Developments
11.15 Towa Yakuhin
11.15.1 Towa Yakuhin Company Information
11.15.2 Towa Yakuhin Acyclovir Analogues Product Offered
11.15.3 Towa Yakuhin Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Towa Yakuhin Main Business Overview
11.15.5 Towa Yakuhin Latest Developments
11.16 Wockhardt
11.16.1 Wockhardt Company Information
11.16.2 Wockhardt Acyclovir Analogues Product Offered
11.16.3 Wockhardt Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Wockhardt Main Business Overview
11.16.5 Wockhardt Latest Developments
11.17 Takata Pharmaceutical
11.17.1 Takata Pharmaceutical Company Information
11.17.2 Takata Pharmaceutical Acyclovir Analogues Product Offered
11.17.3 Takata Pharmaceutical Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Takata Pharmaceutical Main Business Overview
11.17.5 Takata Pharmaceutical Latest Developments
11.18 Aliud
11.18.1 Aliud Company Information
11.18.2 Aliud Acyclovir Analogues Product Offered
11.18.3 Aliud Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Aliud Main Business Overview
11.18.5 Aliud Latest Developments
11.19 Amneal Pharma
11.19.1 Amneal Pharma Company Information
11.19.2 Amneal Pharma Acyclovir Analogues Product Offered
11.19.3 Amneal Pharma Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Amneal Pharma Main Business Overview
11.19.5 Amneal Pharma Latest Developments
11.20 Apotex
11.20.1 Apotex Company Information
11.20.2 Apotex Acyclovir Analogues Product Offered
11.20.3 Apotex Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Apotex Main Business Overview
11.20.5 Apotex Latest Developments
11.21 Arrow
11.21.1 Arrow Company Information
11.21.2 Arrow Acyclovir Analogues Product Offered
11.21.3 Arrow Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Arrow Main Business Overview
11.21.5 Arrow Latest Developments
11.22 Laboratoires Servier
11.22.1 Laboratoires Servier Company Information
11.22.2 Laboratoires Servier Acyclovir Analogues Product Offered
11.22.3 Laboratoires Servier Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Laboratoires Servier Main Business Overview
11.22.5 Laboratoires Servier Latest Developments
11.23 Sanofi
11.23.1 Sanofi Company Information
11.23.2 Sanofi Acyclovir Analogues Product Offered
11.23.3 Sanofi Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Sanofi Main Business Overview
11.23.5 Sanofi Latest Developments
11.24 Mylan
11.24.1 Mylan Company Information
11.24.2 Mylan Acyclovir Analogues Product Offered
11.24.3 Mylan Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Mylan Main Business Overview
11.24.5 Mylan Latest Developments
11.25 Orion Pharma
11.25.1 Orion Pharma Company Information
11.25.2 Orion Pharma Acyclovir Analogues Product Offered
11.25.3 Orion Pharma Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Orion Pharma Main Business Overview
11.25.5 Orion Pharma Latest Developments
11.26 Pfizer
11.26.1 Pfizer Company Information
11.26.2 Pfizer Acyclovir Analogues Product Offered
11.26.3 Pfizer Acyclovir Analogues Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Pfizer Main Business Overview
11.26.5 Pfizer Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
